Skip to main content
. Author manuscript; available in PMC: 2023 Aug 22.
Published in final edited form as: J Pharm Pract. 2020 Feb 18;34(5):734–740. doi: 10.1177/0897190020904590

Table 1.

Descriptive Characteristics and Bivariate Relationships Between Select Characteristics and Willingness to Discuss PrEP With Pharmacy Staff and Screen for PrEP in a Pharmacy Among MSM Who Had Never Taken PrEP in Atlanta, Georgia.a

Pharmacy-Based PrEP Discussion
Pharmacy-Based PrEP Screening
n
%
n
%
179
69.11
159
61.38

Sociodemographic Distribution of Characteristics Yes No P Value Yes No P Value

Age (median, IQR) 31.92 (23, 38) 30.72 (23, 35) 34.07 (25, 44) .0980 30.21 (22, 35) 34.92 (25, 43) .0062

n % % P Value % P Value

Race
 Black, Non-Hispanic 148 57.14 70.42 .8584 57.34 .0692
 White, Non-Hispanic 87 33.59 73.81 70.24
 Hispanic 24 9.27 70.83 75.00
Education
 High school or less 65 25.69 66.67 .4268 62.90 .9337
 College 157 62.06 75.00 63.40
 Advanced degree 31 12.25 68.97 66.67
Employed
 Yes 231 89.19 71.75 .8807 63.84 .6408
 No 28 10.81
Income
 < US$10K 43 16.80 66.67 .0133 59.52 .8714
 US$10K–US$19K 38 14.84 83.33 64.86
 US$20K–US$49K 98 38.28 67.02 65.96
 ≥US$50K 77 30.08 74.67 61.33
Health insurance
 Yes 192 75.89 75.00 .0306 64.02 .7191
 No 61 24.11 60.34 61.40
Homeless
 Yes 27 10.42 69.57 .8203 62.50 .9279
 No 232 89.58 71.81 63.44
Risk behaviors, STIs, and HIV
Number of male sexual partners
 0 23 9.16 61.90 .3646 66.67 .6615
 1–5 198 78.88 71.35 61.98
 >5 30 11.95 80.00 70.00
Number of HIV+ partners
 0 222 87.06 73.83 .1150 64.49 .4426
 ≥1 33 12.94 60.61 57.58
Anal condom use
 Yes 155 62.50 74.50 .3110 67.33 .2093
 No 93 37.50
Condom use
 Consistent 46 19.57 62.22 .0967 54.35 .1193
 Inconsistent 189 80.43 74.59 66.67
Drug use
 Cocaine 13 5.12 72.73 .2671 54.55 .2011
 Methamphetamine 9 3.53 42.86 .0830 71.43 .2885
 Crack 5 1.98 50.00 .2473 50.00 .3260
 Heroin 5 1.98 75.00 .4202 50.00 .3271
Prescription opioid 10 3.95 77.78 .2842 55.56 .2370
 Any drug 27 10.47 66.67 .5730 54.17 .3345
 Any STI 12 4.71 66.67 .2660 87.50 .1131
HIV status
 Negative 233 91.02 72.93 .3612 63.32 .9888
 Never tested/unknown 23 8.98 63.16 63.16
Heard of PrEP
 Yes 216 85.38 72.99 .2187 64.45 .4806
 No 37 14.62 62.86 58.33
Interested in PrEP
 Yes 148 60.16 88.66 <.0001 93.81 <.0001
 No 98 39.84 61.44 43.84
Pharmacy visits
 Frequently 111 42.86 71.03 .9411 60.75 .2380
 Infrequently 116 44.79 71.43 68.42
 Never 32 12.36 74.19 53.33

Abbreviations: IQR, interquartile range; PrEP, pre-exposure prophylaxis; STI, sexually transmitted infection.

a

N = 259.